NBI visualized non-muscle-invasive bladder cancer lesions in 17% more patients and 24% more tumors than white light.
Once-weekly subcutaneous injection of Trulicity (dulaglutide), a glucagon-like peptide-1 receptor agonist.
Blocks reabsorption of glucose by kidneys.
The product is self-administered via a nasal applicator.
FDA clears albiglutide as an adjunct to diet and exercise for glycemic control in adult type 2 diabetes patients.
Astellus Pharma and Medivation ask the FDA to approve enzalutamide as a treatment for advanced prostate cancer in chemotherapy-naïve men.
However, device doesn't perform as well in children as in adults, FDA says.
Agency pointed to recent studies citing possible heightened heart risk tied to the treatments.
To be used along with proper diet and exercise.
Not all experts are happy with granting wider access to the troubled medication, however.
UroLift system, a permanent implant, helps relieve blocked urine flow.
Products may distract consumers from seeking legitimate medical treatment.
Radium-223, a first-in-class drug, travels directly to the site of bone metastases, where it emits alpha particles that exert an anti-tumor effect.
Interactive tool designed to educate patients and advocates about processes of drug development.
Canagliflozin blocks reabsorption of glucose in the kidney, increases glucose excretion, and lowers blood glucose levels.
NEPHROLOGY & UROLOGY NEWS
- Acute Kidney Injury (AKI)
- Chronic Kidney Disease (CKD)
- Contrast Nephropathy
- Cardiovascular Disease (CVD)
- Diabetic Nephropathy
- End-stage Renal Disease (ESRD)
- Lupus Nephritis
- Peritoneal Dialysis
- Secondary Hyperparathyroidism (SHPT)